Browsing by Author "Zouein, Fouad A."
Now showing items 1-8 of 8
-
Acute exposure to cigarette smoking followed by myocardial infarction aggravates renal damage in an in vivo mouse model
Kobeissy, Firas; Shaito, Abdullah; Kaplan, Abdullah; Baki, Lama; Hayek, Hassan; Dagher-Hamalian, Carole; Nehme, Ali; Ghali, Rana; Abidi, Emna; Husari, Ahmad; Zeidan, Asad; Zouein, Fouad A.; Zibara, Kazem... more authors ... less authors ( Hindawi Limited , 2017 , Article)Cigarette smoking (S) is a risk factor for progressive chronic kidney disease, renal dysfunction, and renal failure. In this study, the effect of smoking on kidney function was investigated in a mouse model of myocardial ... -
Advances in Cardiovascular Biomarker Discovery.
Ghantous, Crystal M; Kamareddine, Layla; Farhat, Rima; Zouein, Fouad A; Mondello, Stefania; Kobeissy, Firas; Zeidan, Asad... more authors ... less authors ( MDPI , 2020 , Article Review)Cardiovascular diseases are the leading causes of mortality worldwide. Among them, hypertension and its pathological complications pose a major risk for the development of other cardiovascular diseases, including heart ... -
Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction
El Dahan, Karim Seif; Machtoub, Dima; Massoud, Gaelle; Nasser, Suzanne A.; Hamam, Bassam; Kobeissy, Firas; Zouein, Fouad A.; Eid, Ali H.... more authors ... less authors ( Bentham Science Publishers , 2022 , Article)Cannabis is the most widely trafficked and abused illicit drug due to its calming psychoactive properties. It has been increasingly recognized as having potential health benefits and relatively less adverse health effects ... -
Editorial: Methods and application in cardiovascular and smooth muscle pharmacology: 2021
El-Yazbi, Ahmed F.; Eid, Ali H.; Zouein, Fouad A.; Abd-Elrahman, Khaled S. ( Frontiers Media S.A. , 2022 , Other)Despite significant advances in basic, translational, and clinical research tackling heart disease, cardiovascular pathologies remain among the leading causes of mortality and morbidity worldwide, being responsible for ... -
Macrophage responses associated with COVID-19: A pharmacological perspective
Booz, George W.; Altara, Raffaele; Eid, Ali H.; Wehbe, Zena; Fares, Souha; Zaraket, Hassan; Habeichi, Nada J.; Zouein, Fouad A.... more authors ... less authors ( Elsevier , 2020 , Article)COVID-19 has caused worldwide death and economic destruction. The pandemic is the result of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has demonstrated high rates of infectivity leading to great ... -
The march of pluripotent stem cells in cardiovascular regenerative medicine.
Abou-Saleh, Haissam; Zouein, Fouad A; El-Yazbi, Ahmed; Sanoudou, Despina; Raynaud, Christophe; Rao, Christopher; Pintus, Gianfranco; Dehaini, Hassan; Eid, Ali H... more authors ... less authors ( BMC , 2018 , Article Review)Cardiovascular disease (CVD) continues to be the leading cause of global morbidity and mortality. Heart failure remains a major contributor to this mortality. Despite major therapeutic advances over the past decades, a ... -
MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.
Dehaini, Hassan; Awada, Hussein; El-Yazbi, Ahmed; Zouein, Fouad A; Issa, Khodr; Eid, Assaad A; Ibrahim, Maryam; Badran, Adnan; Baydoun, Elias; Pintus, Gianfranco; Eid, Ali H... more authors ... less authors ( MDPI , 2019 , Article)Ischemia-Reperfusion (I/R) injury is the tissue damage that results from re-oxygenation of ischemic tissues. There are many players that contribute to I/R injury. One of these factors is the family of microRNAs (miRNAs), ... -
Worsening baroreflex sensitivity on progression to type 2 diabetes: Localized vs. systemic inflammation and role of antidiabetic therapy
Bakkar, Nour-Mounira Z.; Mougharbil, Nahed; Mroueh, Ali; Kaplan, Abdullah; Eid, Ali H.; Fares, Souha; Zouein, Fouad A.; El-Yazbi, Ahmed F.... more authors ... less authors ( American Physiological Society , 2020 , Article)Cardiac autonomic neuropathy (CAN) is an early cardiovascular manifestation of type 2 diabetes (T2D) that constitutes an independent risk factor for cardiovascular mortality and morbidity. Nevertheless, its underlying ...